These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 19474567)

  • 21. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.
    de Jager CA; Milwain E; Budge M
    Psychol Med; 2002 Apr; 32(3):483-91. PubMed ID: 11989993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects.
    Schönknecht P; Pantel J; Kruse A; Schröder J
    Am J Psychiatry; 2005 Nov; 162(11):2071-7. PubMed ID: 16263846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laptop-Administered NIH Toolbox and Cogstate Brief Battery in Community-Dwelling Black Adults: Unexpected Pattern of Cognitive Performance between MCI and Healthy Controls.
    Kairys A; Daugherty A; Kavcic V; Shair S; Persad C; Heidebrink J; Bhaumik A; Giordani B
    J Int Neuropsychol Soc; 2022 Mar; 28(3):239-248. PubMed ID: 33752763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary normative neuropsychological data for an elderly chinese population.
    Lee CK; Collinson SL; Feng L; Ng TP
    Clin Neuropsychol; 2012; 26(2):321-34. PubMed ID: 22288384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality.
    Sánchez JL; Rodríguez M; Carro J
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):113-22. PubMed ID: 12050474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS).
    Hobson VL; Hall JR; Humphreys-Clark JD; Schrimsher GW; O'Bryant SE
    Int J Geriatr Psychiatry; 2010 May; 25(5):525-30. PubMed ID: 19862695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data.
    Conca F; Esposito V; Rundo F; Quaranta D; Muscio C; Manenti R; Caruso G; Lucca U; Galbussera AA; Di Tella S; Baglio F; L'Abbate F; Canu E; Catania V; Filippi M; Mattavelli G; Poletti B; Silani V; Lodi R; De Matteis M; Stanzani Maserati M; Arighi A; Rotondo E; Tanzilli A; Pace A; Garramone F; Cavaliere C; Pardini M; Rizzetto C; Sorbi S; Perri R; Tiraboschi P; Canessa N; Cotelli M; Ferri R; Weintraub S; Marra C; Tagliavini F; Catricalà E; Cappa SF
    Alzheimers Res Ther; 2022 Aug; 14(1):113. PubMed ID: 35982477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
    de Jager CA
    Neurol Res; 2004 Jul; 26(5):481-7. PubMed ID: 15362213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a European Cross-Cultural Neuropsychological Test Battery (CNTB) for evaluation of dementia.
    Nielsen TR; Segers K; Vanderaspoilden V; Beinhoff U; Minthon L; Pissiota A; Bekkhus-Wetterberg P; Bjørkløf GH; Tsolaki M; Gkioka M; Waldemar G
    Int J Geriatr Psychiatry; 2019 Jan; 34(1):144-152. PubMed ID: 30246268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis.
    Masters MC; Morris JC; Roe CM
    Neurology; 2015 Feb; 84(6):617-22. PubMed ID: 25589671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
    Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
    Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
    Beach TG; Monsell SE; Phillips LE; Kukull W
    J Neuropathol Exp Neurol; 2012 Apr; 71(4):266-73. PubMed ID: 22437338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
    MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
    J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team.
    Ganguli M; Snitz BE; Lee CW; Vanderbilt J; Saxton JA; Chang CC
    Aging Ment Health; 2010 Jan; 14(1):100-7. PubMed ID: 20155526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
    Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations.
    Collie A; Shafiq-Antonacci R; Maruff P; Tyler P; Currie J
    Aust N Z J Psychiatry; 1999 Aug; 33(4):568-75. PubMed ID: 10483853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB).
    Mistridis P; Egli SC; Iverson GL; Berres M; Willmes K; Welsh-Bohmer KA; Monsch AU
    Eur Arch Psychiatry Clin Neurosci; 2015 Aug; 265(5):407-17. PubMed ID: 25555899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.